Form 4: Alaunos Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Robert W Postma, a Director of Alaunos Therapeutics, Inc., received 21,829 shares of common stock on October 6, 2026.
Summary
- Grant/award: acquired 21,829 Common Stock at $0.74 ($16,250) on October 6, 2026; holds 80,438 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert W Postma — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Grant/award | Common Stock | 21,829 | $1 | $16.2K | 80,438 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Grant/award (21,829 shares) |
Keywords
insider transaction, Form 4, TCRT, Alaunos Therapeutics, Inc., neutral, Robert W Postma
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.